A limited company with predominantly
public share capital

The LFB Group, a French biopharmaceutical company, is a limited company
with predominantly public share capital, the French State
now being the sole shareholder.

Group organisation chart

A growing international presence through development and by setting up subsidiaries, particularly in Europe.

Group Executive Committee

The Group Executive Committee is chaired by Denis Delval, Chairman and CEO of LFB S.A.

LFB SA Board of Directors

Composition of the LFB SA Board of Directors.

LFB BIOMEDICAMENTS

LFB BIOMEDICAMENTS, a wholly-owned subsidiary of LFB SA, specialises in plasma-derived medicinal products. It is headed by Denis Delval.

LFB BIOTECHNOLOGIES

LFB BIOTECHNOLOGIES, a wholly-owned subsidiary of LFB SA, has its head office in Les Ulis (France) and is a strategic subsidiary of the LFB Group.

Composition and tasks of the Committees

Composition and tasks of the Audit and Compensation committee and the strategy committee